Biocracked
Approach 4, conceptual metaphor, with palette D, bold color field.

A single cross-section of a rusted, mineral-crusted copper pipe stands upright at center, shot from a slightly low three-quarter angle with a shallow depth of field. Its inner wall is thickly lined with chalky white-orange scale that narrows the bore to a small opening. One side of the buildup is hard and crystalline, while the other side is softer and still forming. A thin, clean ribbon of electric green liquid (#00e676) runs through the remaining channel, a subtle accent. The backdrop is a seamless saturated mustard-yellow field. Hard, directional studio light from upper left casts a crisp, short shadow to the right. Textures are tactile and macro-sharp, with visible grit and flaking. The mood is calm, analytical and slightly cautionary.
Supplements

Vitamin sing Ngerem Pembentukan Kalsium ing Arteri Sajrone 2 Tahun

Nova Chen · · 4 min read

Vitamin sing Ngerem Pembentukan Kalsium ing Arteri Sajrone 2 Tahun

Suplemen sing regane murah lan umum didol iki bisa nindakake apa sing arang‑arange suplemen bisa: nyuda akumulasi kalsium ing arteri koroner kanthi cetha ing uji coba acak. Nanging, saiki durung ana sing ngerti apa iki beneran bisa nyegah serangan jantung.

Suplemen iki yaiku vitamin K2 wujud menaquinone‑7 (MK‑7). Uji coba kasebut dijenengi VitaK‑CAC, lan dipublikasikaké ing JAMA Cardiology taun 2026.

Angka‑angka Pokok

Para peserta duwé penyakit arteri koroner (CAD) sing gejala lan skor kalsium arteri koroner (CAC) ing kisaran 50‑400 unit Agatston (AU). Wong‑wong iku njupuk 360 µg MK‑7 saben dina utawa plasebo sing padha nganti loro taun. Skor CAC median ing saben kelompok owah kaya mengkéné:

Kelompok Baseline Taun 1 Taun 2
Plasebo 145 AU 173 AU 214 AU
MK‑7 (360 µg/hari) 135 AU 150 AU 184 AU

Mula‑mula, kenaikan median kira‑kira 49 AU ing grup MK‑7 lan 69 AU ing grup plasebo. Bédané antar‑kelompok signifikan sacara statistik (P = .02), kalebu sawisé disetel kanggo variabel liya. Massa kalsium, ukuran CT liya, nuduhaké asil sing padha.

Kalsifikasi tetep maju ing grup MK‑7, mung majué luwih alon.

Sapa sing Diteliti

Peneliti randomake 180 pasien (90 ing saben grup) ing siji rumah sakit universitas lan siji rumah sakit komunitas ing Walanda. Analisis nglibataké 85 pasien ing grup MK‑7 lan 82 pasien ing grup plasebo.

  • Umur: median 59 taun (MK‑7) lan 61 taun (plasebo)
  • Jinis kelamin: 42 % wanita ing loro kelompok
  • Kondisi: CAD aterosklerotik sing gejala kanthi kalsium moderat (CAC 50‑400 AU)
  • Keseimbangan awal: loro kelompok padha rata‑rata

Kelompok iki yaiku wong enom‑tengah umur sing wis nduwèni kalsifikasi nanging ora ekstrim. Asil iki mbok menawa ora bisa digeneralisasi kanggo wong sing duwé CAC sing dhuwur banget, tanpa gejala, utawa sing nduwèni penyakit ginjal.

Ora Mung Skor Kalsium: Rincian Plak

Bagéan sing paling menarik saka tulisan iki yaiku panggonan efeké. Para peserta uga nglakokaké CT‑angiografi, sing mbantu peneliti ndelok jinis plak. Kenaikan skor CAC gegandhengan karo jumlah plak non‑kalsifikasi sing dadi sethithik kalsifikasi sajrone panalitèn (R² = 0.17; P = .04).

Interpretasi penulis yaiku MK‑7 bisa mbantu alon‑alon kalsifikasi ing plak non‑kalsifikasi. Korelasi iki ora kuwat banget, amarga R² = 0.17 nuduhaké yèn mayoritas variasi disebabaké faktor liya. Nanging iki maringi mekanisme sing masuk akal, sanajan durung bukti final.

Ana uga cek biologi. Konsentrasi plasma MK‑7 mundhak saka median 0.50 µg/L dadi 6.56 µg/L ing kelompok perlakuan (P < .001), dadi jelas yèn peserta pancen ngonsumsi lan nyerap suplemen. Iki penting, amarga masalah kepatuhan kerep nyegah asil positif ing uji coba suplemen.

Keamanan

Penulis nglaporaké ora ana efek samping signifikan. Kanggo uji coba suplemen rong taun, iki dadi cathetan sing nyenengake, sanajan ukuran sampel ora cukup kanggo ngelola risiko efek samping sing langka.

Apa Sing Durung Dikenal

Ing kéné kudu dijlentrehaké watesan‑watesan penting.

  • Makna klinis durung kabukten. Penulis nyatakake pentingé temuan iki “saka sudut pandang stabilitas plak kudu ditliti luwih lanjut.” Alon‑alon kalsifikasi minangka asil gambar, dudu pengurangan serangan jantung, stroke, utawa mortalitas. Kalsifikasi dhewe iku tandha sing komplek; sawetara plak kalsifikasi malah luwih stabil tinimbang plak lunak, mula alon‑alon kalsifikasi ora mesthi apik.
  • Bédané absolut ora gedhé. Mung watara 20 AU sing misahaké kenaikan median loro kelompok sajrone rong taun.
  • Ukuran uji coba ora gedhé. Kira‑kira 167 pasien sing dianalisis cukup kanggo ndeteksi bédané CAC, nanging ora cukup kanggo acara klinis.
  • Jadwal panalitèn dawa lan kadang ilang. Data diklumpukaké saka 2012 nganti 2022 kanthi “sejumlah gangguan.”
  • Ana kaitan karo industri. Prof Leon Schurgers nglaporaké nampa hibah saka Gnosis by Lesaffre (produsen MK‑7) lan nduwèni saham ing Coagulation Profile, sanajan kalebu “luar saka karya sing dilaporaké.” Iki ora mbatalaké asil, nanging kudu dingertèni. Ana uga komentar ing jurnal sing padha sing ngulas asil iki.

Ringkesan Praktis

Dosis: Uji coba iki nggunakake 360 µg MK‑7 saben dina. Iki siji‑sijine dosis sing nduwèni bukti iki; dosis iki luwih dhuwur tinimbang sing umum ditemokaké ing multivitamin.

Wujud: MK‑7, dudu MK‑4. Penelitian iki mung nguji menaquinone‑7. Dadi hasil iki ora bisa diprakirakaké kanggo MK‑4 utawa vitamin K1.

Cara ngonsumsi: Abstrak ora nyebutaké wektu njupuk suplemen. Vitamin K larut ing lemak, mula biasané njupuk bareng panganan sing ngandhut lemak iku pendekatan sing wajar. Iki ora diuji ing panalitèn iki.

Sapa sing bisa manfaataké: Bukti iki mung berlaku kanggo wong kaya peserta – wong enom‑tengah umur sing duwe CAD simptomatik lan kalsifikasi moderat. Yèn iki cocog karo kahanan sampeyan, iki topik sing pantes kanggo dibahas karo kardiolog.

Sapa sing kudu takon dhisik utawa ora nganggo:

  • Sing ngonsumsi warfarin utawa antagonis vitamin K liya. Vitamin K bakal ngowahi cara kerja obat iki, lan bisa ngowahi INR. Aja mulai MK‑7 tanpa persetujuan dokter.
  • Sing nganggo antikoagulan liya utawa nduwèni riwayat bekuan getih. Wajib takon dhisik karo dokter.
  • Sing ngarep‑arep suplemen iki bakal “mbalikake” kalsifikasi. Uji coba mung nuduhaké alon‑alon progresi, dudu pengurangan.
  • Sing ora nduwèni penyakit jantung. Panalitèn iki ora ngandhut data babagan keuntungan kanggo wong sehat.

Kesimpulan

VitaK‑CAC iku uji coba acak, double‑blind, lan kontrol plasebo sing dirancang apik kanggo nguji gagasan sing masuk akal, lan asilé nuduhaké penurunan signifikan ing laju kalsifikasi koroner kanthi cathetan keamanan sing apik. Iki nyenengake lan menarik saka sisi mekanisme, utamané sinyal ing plak non‑kalsifikasi. Nanging asil iki adhedhasar marker surrogat saka uji coba sing relatif cilik, lan ana deklarasi konflik kepentingan sing kudu digatekake. Nganti ana studi luwih gedhé sing nuduhaké penurunan acara kardiovaskular, MK‑7 tetep dadi tambahan sing patut dibahas karo dokter, dudu solusi utama kanggo penyakit jantung.

Sumber: Vossen LM, de Leeuw PW, Schurgers LJ, et al. Two Years of Menaquinone‑7 Supplementation and Coronary Artery Calcification: A Randomized Clinical Trial. JAMA Cardiology. 2026;11(8):719‑726. doi:10.1001/jamacardio.2026.1279. ClinicalTrials.gov: NCT01002157. PubMed.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

NC

Written by

Nova Chen

Nova Chen writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach: conceptual metaphor. Palette: D, bold color field.

A single cracked ceramic-white bone-shaped column, like a femur section, stands upright at the center of a saturated mustard-yellow seamless backdrop. A thin, clean hairline fracture runs through its middle. Beside it, a small golden-amber glass dropper bottle sits tipped, with one droplet suspended just above the bone and not touching it, which suggests extra vitamin D that makes no difference. The camera is at a low three-quarter angle with a shallow depth of field. Hard, directional studio light from the upper left casts a crisp, long shadow across the yellow floor. The porous bone texture is visible in fine detail. A tiny electric green (#00e676) droplet reflection glints on the glass. The mood is skeptical, cool-headed and editorial.
longevity

Vitamin D Dosis Dhuwur kanggo Balung? Uji Coba Lima Taun Mbuktèkaké Ora

BY DR. SYNAPSE ·

Apa nambah vitamin D nganti dosis dhuwur bisa nyegah fraktur? Uji coba acak limang taun ing 2.495 warga senior Finlandia nemokake yen dosis 1.600 IU utawa 3.200 IU saben dina ora ngurangi risiko fraktur, malah kelompok 1.600 IU ngalami luwih akèh fraktur. Asil iki mung berlaku kanggo wong sing wis nduwèni kadar vitamin D cukup.

Approach: conceptual metaphor. Palette: bold color field (D).

Subject: a clear glass tube-shaped pipe, cut in cross-section, sitting on a saturated mustard-yellow backdrop. Its inner wall is lined with chalky, white mineral crust that narrows the opening on one end and thins out toward the other, showing progression slowing. A single thin electric green thread runs through the clear center as a small accent.

Camera: low three-quarter angle, shallow depth of field, macro lens, with the narrowed end sharp in the foreground and the clear end softly blurred behind.

Lighting: bright, soft studio light from the upper left with crisp highlights on the glass and a clean, warm-grey shadow cast on the yellow surface. No blue cast.

Mood: calm, precise, cautiously optimistic. The mineral texture should look real, gritty and crystalline, not cartoonish. No text or labels.
supplements

720 mcg Vitamin K2 + D3 Ngerem Kalikasi Arteri nganti 21 % ing RCT

BY DR. SYNAPSE ·

Panlitén double‑blind rong taun kanthi 400 subjek sing nduwèni kalikasi koroner parah nemokaké yèn dosis dhuwur vitamin K2 lan D3 ngurangi pertumbuhan kalsium ing arteri kira‑kira 21 % tinimbang plasebo (196 vs 248 AU). Pencitraan plak ora nuduhaké nambahé plak non‑kalkifikasi, sing dadi pratandha nyenengaké. Nanging suplemen mung ngerem progresi, ora mbalèkaké kalsium sing wis ana, lan ora ana data babagan serangan jantung utawa mortalitas. Peserta mayoritas wong tuwa (median umur 71 taun) kanthi penyakit tahap akhir, saéngga asil ora mesthi ditrapaké kanggo kabèh wong. Ing ngisor iki sing ditampilaké DANCODE trial, apa sing ora ditampilaké, lan kenapa wong sing njupuk warfarin kudu rembugan dhisik karo dhokter.

Macro photograph at a low 30-degree angle of two tiny mounds on a glossy, saturated teal acrylic surface. The left mound is orange-yellow CoQ10 crystalline powder with visible faceted flakes. The right mound is dull metallic grey selenium granules. A hairline crack runs across the acrylic between them, hinting at the catch. Hard, clean studio light from the upper left throws crisp, short shadows and sparkles on the crystal edges. The background falls softly out of focus, with a thin electric green reflection streaking across the glossy surface. The palette is bold color field: teal against orange, with silver-grey accents. The mood is precise, curious and cautionary, like a lab specimen photographed for a magazine. Photorealistic, shallow depth of field, no text.
longevity

Loro Suplemen Murah Sing Ngurangi Kematian Jantung nganti Setengah: Ana Pengecualian

BY NOVA CHEN ·

Loro suplemen regane terjangkau, CoQ10 lan selenium, kacemplungake karo penurunan kematian kardiovaskular saka 12,6 % dadi 5,9 % ing warga senior Swedia. Biomarker stres jantung lan ekokardiogram uga nuduhaké perbaikan. Nanging panalitèn iki mung ndarbeni 443 wong saka negara sing seleniumé kurang, lan ora bisa nemtokaké suplemen endi sing dadi penyebab utama. Artikel iki nerangaké apa sing sejatine dituduhaké studi KiSel‑10, sapa sing bisa entuk manfaat, lan wates keamanan sing kudu dipahami sadurunge nyoba.

Approach: Macro science. Palette: D, bold color field.

An extreme close-up microscopy-style photograph of a single giant megakaryocyte cell, a large lumpy, lobed cell with a textured, slightly translucent surface, budding off dozens of tiny, smooth, disc-shaped platelets that drift away on fine stringy extensions. The cell and platelets are a warm pearly ivory with subtle coral-pink internal granules and a few small electric green (#00e676) fluorescent specks inside, suggesting recycling vesicles. The backdrop is a saturated, even tomato-red to deep orange color field with a soft gradient. Shot from slightly above at a three-quarter angle, with shallow depth of field so the nearest platelets are crisp and the distant ones melt into soft blur. Lighting is clean, diffuse and glowing from behind, giving gentle rim highlights. Mood: curious, precise, quietly cautionary. No text.
longevity

CoQ10 Ngerem Trombosit Lawas ing Tikus Tuwa — Ana Trikane Kene

BY NOVA CHEN ·

Studi anyar ing *Aging Cell* nglaporake yèn CoQ10 nambah fungsi megakariosit lawas ing tikus. Tikus sing diwènèhi CoQ10 nuduhaké agregasi trombosit lan aktivasi sing luwih sithik, sanajan cacah trombosit ora owah. Pengaruh iki katingal liwat COPS3 lan autophagy, sistem daur ulang sel. Nanging riset iki mung ing tikus lan sel laboratorium, ora ana data manungsa lan ora ana bukti pencegahan beku. Mula, wong sing nganggo antikoagulan kudu takon dhokter dhisik.

This page is available in